Xarelto Lawsuit News Update: Location of the Xarelto MDL to be determined soon by the Judicial Panel on Multi-District Litigation

Share Article

The Xarelto attorneys at Niemeyer, Grebel, & Kruse LLC announce new website offering no-obligation Xarelto lawsuit evaluation for individuals that have suffered from bleeding events and hemorrhagic stroke allegedly linked to Xarelto.

The makers of Xarelto sold the drug on the idea that individuals do not need to submit to monthly blood tests

Niemeyer, Grebel & Kruse, LLC, is proud to announce that it has launched the new website http://www.xareltorivaroxabanlawcenter.com. The site is devoted to helping those allegedly injured by the blood thinning medication Xarelto understand their avenues for pursuing a Xarelto lawsuit. NGK Law is a nationally recognized law firm that handles pharmaceutical drug and medical device cases throughout the United States. The Xarelto attorneys at NGK Law routinely handle pharmaceutical and medical device cases throughout the country, and have been repeatedly recognized for their expertise in handling cases such as Xarelto lawsuits.

Owing to NGK Law’s expertise with pharmaceutical cases, the Federal Court in the Southern District of Illinois appointed NGK Law partner Mark Niemeyer as the Liaison Counsel for the entire multi-district litigation (MDL) for Pradaxa bleeding lawsuits. The Pradaxa MDL is a consolidation of thousands of Pradaxa bleeding lawsuits. In his role as Pradaxa Liaison counsel, Mark Niemeyer was instrumental in running and ultimately resolving the Pradaxa lawsuits. Pradaxa is a blood thinner very similar to Xarelto. Both Xarelto and Pradaxa were developed to replace Coumadin, a blood thinner that has been around since the 1950s. Blood thinners are used for those individuals that have suffered clotting events in the past to thin the blood and decrease the risk of future clotting events.

The Institute for Safe Medication Practices, in its May 7, 2014 Quarter Watch report, noted an increase in reporting to the FDA of serious adverse events in individuals taking Xarelto. The adverse events were bleeding events such as gastrointestinal bleeds and hemorrhagic strokes. The ISMP’s report detailed that by the end of 2013, the volume of adverse events involving Xarelto were steadily increasing and outnumbered Pradaxa bleeding events. This concern led to the attorneys at NGK Law investigating whether or not there were grounds for a Xarelto lawsuit.

NGK Law has already filed a Xarelto lawsuit in the U.S. District Court for the Southern District of Illinois, Williams v. Janssen Research & Development, LLC et. al, Cause no. 3:14 cv-01278. In NGK Law’s Xarelto lawsuit, it is alleged that one of the primary concerns about Xarelto is that while individuals are taking Xarelto, they do not need to have their blood levels routinely monitored. It is further alleged that while individuals are taking Coumadin, individuals must submit to monthly blood tests to make sure they are receiving the right dose of Coumadin. The lawsuit claims that the makers of Xarelto sold the drug on the idea that individuals do not need to submit to monthly blood tests, and therefore Xarelto is more convenient. In filing the Xarelto lawsuits, the attorneys at NGK Law have made claims that individuals on Xarelto do, in fact, need to regularly monitor their blood levels. NGK Law’s Xarelto attorneys argue that the lack of monitoring leads to an increase in the risk of bleeding events.

It is expected that the majority of Xarelto lawsuits around the United States will be consolidated into a Xarelto MDL. A hearing is being held in the In re: Xarelto Products Liability Litigation, MDL No. 2592, in which the JPML will determine where the MDL for Xarelto lawsuits will be located. There has been a request that the litigation be sent to the U.S. District Court for the Southern District of Illinois. NGK Law partner Mark Niemeyer has previously been appointed as the lead counsel for the Yaz MDL, and Liaison Counsel for the Pradaxa MDL, both of which were sent to the United States District Court for the Southern District of Illinois. As a result, NGK Law is taking an active role in investigating and handling Xarelto lawsuits for individuals that have suffered from bleeding events after taking Xarelto.

NGK Law is evaluating cases for individuals, or family members of individuals, that have suffered from serious bleeding events, including hemorrhagic strokes and gastrointestinal bleeds, while taking Xarelto. With NGK Law’s experience in leading the Pradaxa MDL and resolving Pradaxa bleeding lawsuits for its clients, NGK Law is well equipped to both investigate and handle your Xarelto bleeding lawsuit. NGK Law’s partners are available to speak with clients directly regarding their unfortunate bleeding events and whether or not they have grounds for a Xarelto bleeding lawsuit. Those that have suffered from bleeding events or hemorrhagic strokes while taking Xarelto can contact NGK Law and its Xarelto attorneys through its website http://www.xareltorivaroxabanlawcenter.com. NGK Law also welcomes the chance to work with other attorneys on Xarelto lawsuits.

About Niemeyer, Grebel & Kruse, LLC

Niemeyer, Grebel & Kruse, LLC is a St. Louis based mass tort and personal injury law firm handling pharmaceutical and medical device injury and death cases around the United States. Its track record of assisting those injured by dangerous drugs and medical devices shows its unending commitment to its clients and to holding pharmaceutical drug manufacturers and medical device manufacturers accountable for their dangerous products. Given its experience and accomplishment in being recognized by federal courts to lead litigation on behalf of thousands of individuals, NGK Law is considered a nationwide leader in pharmaceutical and drug litigation. The NGK Law Firm Xarelto lawyers provide information to the public at http://www.xareltorivaroxabanlawcenter.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Grebel
NGK Law Firm
+1 314-241-1919
Email >
Visit website